Privia Health Group (NASDAQ:PRVA) versus Aspyra (OTCMKTS:APYI) Critical Survey

Aspyra (OTCMKTS:APYI) and Privia Health Group (NASDAQ:PRVA) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.

Analyst Ratings

This is a breakdown of recent recommendations for Aspyra and Privia Health Group, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aspyra	0	0	0	0	0.00
Privia Health Group	0	3	13	0	2.81

Privia Health Group has a consensus target price of $30.50, indicating a potential upside of 30.29%. Given Privia Health Group’s stronger consensus rating and higher possible upside, analysts plainly believe Privia Health Group is more favorable than Aspyra.

Profitability

This table compares Aspyra and Privia Health Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aspyra	N/A	N/A	N/A
Privia Health Group	0.89%	2.52%	1.47%

Volatility and Risk

Aspyra has a beta of 2.14, indicating that its share price is 114% more volatile than the S&P 500. Comparatively, Privia Health Group has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500.

Valuation and Earnings

This table compares Aspyra and Privia Health Group”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aspyra	N/A	N/A	N/A	N/A	N/A
Privia Health Group	$1.74 billion	1.66	$14.39 million	$0.13	180.08

Privia Health Group has higher revenue and earnings than Aspyra.

Institutional and Insider Ownership

94.5% of Privia Health Group shares are owned by institutional investors. 23.9% of Aspyra shares are owned by insiders. Comparatively, 10.7% of Privia Health Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Privia Health Group beats Aspyra on 8 of the 10 factors compared between the two stocks.

About Aspyra

Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. It offers engineered workflow solutions that include software, interfaces, hardware, and professional services to various markets comprising specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company was formerly known as Creative Computer Applications Inc. and changed its name to Aspyra Inc. in November 2005. Aspyra Inc. was founded in 1978 and is headquartered in Jacksonville, Florida.

About Privia Health Group

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.